Literature DB >> 6092906

Characterization of the acquired immune deficiency syndrome at the cellular and molecular level.

D J Barrett.   

Abstract

The acquired immunodeficiency syndrome (AIDS) is a new disease characterized by severe dysfunction of both the T cell and B cell systems, occurring in previously healthy individuals. Affected individuals may have recurrent and chronic opportunistic infections and/or Kaposi's sarcoma or other malignancy. Analysis of the cellular and subcellular components of immunity demonstrates a profound depression in the number and function of helper/inducer T cells bearing the OKT4 (Leu 3) differentiation antigen and a concomitant defect in the synthesis of the immuno-enhancing soluble growth factor, interleukin 2 (IL-2). Hypotheses to explain the etiology of the immunological dysfunction and implications for future therapy of AIDS are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092906     DOI: 10.1007/bf00230156

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  56 in total

1.  Hepatitis B surface antigen could harbour the infective agent of AIDS.

Authors:  M I McDonald; J D Hamilton; D T Durack
Journal:  Lancet       Date:  1983-10-15       Impact factor: 79.321

2.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

3.  Altered distribution of T-lymphocyte subpopulations in lymph nodes from patients with acquired immunodeficiency-like syndrome and hemophilia.

Authors:  P R Meyer; R L Modlin; D Powars; N Ewing; J W Parker; C R Taylor
Journal:  J Pediatr       Date:  1983-09       Impact factor: 4.406

4.  Acquired immunodeficiency syndrome in infants.

Authors:  G B Scott; B E Buck; J G Leterman; F L Bloom; W P Parks
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

5.  Epidemic of acquired immunodeficiency in rhesus monkeys.

Authors:  R V Henrickson; D H Maul; K G Osborn; J L Sever; D L Madden; L R Ellingsworth; J H Anderson; L J Lowenstine; M B Gardner
Journal:  Lancet       Date:  1983-02-19       Impact factor: 79.321

6.  Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome.

Authors:  C Harris; C B Small; R S Klein; G H Friedland; B Moll; E E Emeson; I Spigland; N H Steigbigel
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

7.  Immune deficiency syndrome in children.

Authors:  J Oleske; A Minnefor; R Cooper; K Thomas; A dela Cruz; H Ahdieh; I Guerrero; V V Joshi; F Desposito
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

8.  Suppression of the humoral antibody response in natural retrovirus infections.

Authors:  Z Trainin; D Wernicke; H Ungar-Waron; M Essex
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants.

Authors:  J Vieira; E Frank; T J Spira; S H Landesman
Journal:  N Engl J Med       Date:  1983-01-20       Impact factor: 91.245

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  2 in total

1.  Increased interleukin-2 receptor expression after mitogen stimulation on CD4- and CD8-positive lymphocytes and decreased interleukin-2 production in HTLV-III antibody-positive symptomatic individuals.

Authors:  P C Creemers; M O'Shaughnessy; W J Boyko
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

Review 2.  Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human Studies.

Authors:  Rodney R Dietert
Journal:  Adv Med       Date:  2014-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.